Scarica l'app Stockscreener
35.83
7.05%
2.36
Dopo l'orario di chiusura:
36.36
0.53
+1.48%
Septerna Inc Borsa (SEPN) Ultime notizie
SEPN Q1 2026 Earnings: Smaller-than-expected loss as clinical-stage biotech advancesEarnings Yield Spread - dars.gov.et
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? - Yahoo Finance
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? - The Motley Fool
Septerna (SEPN) SVP Long exercises options and sells 3,333 shares in Rule 10b5-1 trades - Stock Titan
Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment? - Yahoo Finance
Septerna Inc. (SEPN) Slides 2.63% as Stock Tests Key Support Near $32Max Pain Level - dars.gov.et
Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR) - The Globe and Mail
SEPN Maintained by Guggenheim -- Price Target Lowered to $45.00 - GuruFocus
Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating - marketscreener.com
SEPN Maintains Buy RatingPrice Target Raised to $43.00 by Tru - GuruFocus
SEPN Reiterated by HC Wainwright & Co. -- Price Target Maintained at $40 - GuruFocus
Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed? - simplywall.st
Analysts Are Bullish on Top Technology Stocks: Akamai (AKAM), Procore Technologies (PCOR) - The Globe and Mail
Septerna stock maintained at Buy by H.C. Wainwright after rival setback - Investing.com
Guggenheim cuts Septerna stock price target to $45 on CSU study risk - Investing.com
H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Truist raises Septerna stock price target to $43 on hypoparathyroidism outlook - Investing.com
5 Best Up and Coming Pharmaceutical Stocks to Buy Now - Insider Monkey
Septerna, Inc. Files 8-K Detailing Annual Meeting Results and Company Information – June 2026 - Minichart
Septerna chief people officer Samira Shaikhly sells $76,622 in stock - Investing.com UK
Form 4 Septerna Inc For: 30 June By Investing.com - Investing.com UK
Septerna (NASDAQ: SEPN) director-linked funds get 15,000-share option - Stock Titan
Septerna chief people officer Samira Shaikhly sells $76,622 in stock By Investing.com - Investing.com South Africa
Septerna (SEPN) CPO exercises options and sells 2,178 shares - Stock Titan
Septerna (SEPN) director Shalini Sharp receives stock options on 15,000 shares - Stock Titan
Septerna (SEPN) director Abraham Bassan receives grant of 15,000 stock options - Stock Titan
Septerna (SEPN) director granted 15,000 options for RA Capital funds - Stock Titan
Septerna (NASDAQ: SEPN) 2026 meeting elects directors and backs EY as auditor - Stock Titan
Cantor Fitzgerald Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $60 - Moomoo
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares? - Yahoo Finance
ETFs Investing in Septerna, Inc. Stocks - TradingView
Septerna Inc. (SEPN) Drops 8.4%: Key Support and Resistance Levels in FocusTick Index - dars.gov.et
Septerna, Inc.(NasdaqGM: SEPN) added to Russell 2000 Growth Benchmark - marketscreener.com
Septerna, Inc.(NasdaqGM: SEPN) added to Russell 3000E Growth Benchmark - marketscreener.com
SEPN Q1 2026 Earnings: EPS Beat Signals Efficient Cash ManagementDividend Growth Analysis - dars.gov.et
Septerna, Inc.(NasdaqGM: SEPN) added to Russell 2500 Growth Benchmark - marketscreener.com
SEPN Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock RallyMargin Improvement Report - dars.gov.et
Form 144 SEPTERNA For: 26 June By Investing.com - Investing.com South Africa
SEPN (NASDAQ) insider sale: JAE KIM sells 94,339 shares under Rule 144 - Stock Titan
Septerna obtains promising preclinical results with SEP-479 for hypoparathyroidism - BioWorld News
Septerna Inc (SEPN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Septerna, Inc. Actuals & Estimates (NASDAQ:SEPN) - TradingView
Septerna, Inc. (SEPN) reports Q1 loss, tops revenue estimates - MSN
SEPN Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Septerna Inc For: 24 June By Investing.com - Investing.com UK
Septerna SVP, drug discovery, sells $532,581 in stock By Investing.com - Investing.com South Africa
Septerna SVP, drug discovery, sells $532,581 in stock - Investing.com
Septerna (SEPN) SVP sells 15,000 shares under 10b5-1 plan - Stock Titan
Septerna stock hits all-time high at 37.32 USD By Investing.com - Investing.com South Africa
Septerna stock hits all-time high at 37.32 USD - Investing.com
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):